Cationic host defense (antimicrobial) peptides.

By K. Brown, Robert E. W. Hancock. Current Opinion in Immunology, 2006

836 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Multifunctional cationic host defence peptides and their clinical applications (2011, background): “Virtually all cationic peptides have direct antimicrobial activity in vitro under the appropriate conditions, especially in situations where the peptides are tested at very high concentrations or in dilute medium [ 12 , 32, 67].”
Development, cytokine profile and function of human interleukin 17–producing helper T cells (2007, background): “It is becoming increasingly apparent that epithelial cells are key to host defense through the production of inflammatory cytokines and antimicrobial molecule”
Antimicrobial Peptides (2013, background): “Historically AMPs have also been referred to as cationic host defense peptides [1], anionic antimicrobial peptides/proteins [2], cationic amphipathic peptides [3], cationic AMPs [4], host defense”
Antibiotic resistance: a rundown of a global crisis (2018, background): “The amphipathic nature of AMPs enables interaction and insertion into the cell wall and cellular membranes of microbes.(90) Although AMPs usually demonstrate antimicrobial activity because of damage to the”
Human Host Defense Peptide LL-37 Prevents Bacterial Biofilm Formation (2008, background): “abilities to modulate immunity as part of the innate immune response, and they demonstrate promise as a new approach to antimicrobial therapy (4, 5, 8).”